BHC Return on Tangible Equity | Bausch Health Companies Inc.

Bausch Health Companies Inc. (BHC) Return on Tangible Equity

2026-06-30: Return Tang Equity 7.87%.
2026-03-31: Return Tang Equity 8.35%.
2025-12-31: Return Tang Equity -1.07%.
2025-09-30: Return Tang Equity -2.43%.

Complete source-backed return tang equity history.

Available history: 2008-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	7.87%
2026-03-31	8.35%
2025-12-31	-1.07%
2025-09-30	-2.43%
2025-06-30	-0.64%
2025-03-31	0.25%
2024-12-31	0.29%
2024-09-30	1.09%
2024-06-30	2.85%
2024-03-31	2.72%
2023-12-31	3.49%
2023-09-30	5.54%
2023-06-30	1.17%
2023-03-31	2.20%
2022-12-31	1.38%
2022-09-30	-1.50%
2022-06-30	-0.24%
2022-03-31	2.32%
2021-12-31	5.32%
2021-09-30	6.42%
2021-06-30	6.73%
2021-03-31	5.37%
2020-12-31	2.91%
2020-09-30	9.75%
2020-06-30	10.14%
2020-03-31	9.31%
2019-12-31	8.70%
2019-09-30	3.12%
2019-06-30	4.55%
2019-03-31	7.92%
2018-12-31	20.04%
2018-09-30	15.62%
2018-06-30	7.64%
2018-03-31	3.73%
2017-12-31	-10.38%
2017-09-30	-5.67%
2017-06-30	4.14%
2017-03-31	5.00%
2016-12-31	8.14%
2016-09-30	7.17%
2016-06-30	3.14%
2016-03-31	2.30%
2015-12-31	0.86%
2015-09-30	-1.94%
2015-06-30	-2.63%
2015-03-31	-8.14%
2014-12-31	-6.58%
2014-09-30	-3.60%
2014-06-30	5.36%
2014-03-31	5.59%
2013-12-31	5.68%
2013-09-30	7.02%
2013-06-30	1.18%
2013-03-31	-1.20%
2012-12-31	-3.23%
2012-09-30	-0.50%
2012-06-30	-2.81%
2012-03-31	-2.65%
2011-12-31	-0.17%
2011-09-30	-19.65%
2011-06-30	-12.90%
2011-03-31	-10.49%
2010-12-31	-11.97%
2010-09-30	5.28%
2010-06-30	29.70%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-1.07%
2024-12-31	0.29%
2023-12-31	3.49%
2022-12-31	1.38%
2021-12-31	5.32%
2020-12-31	2.91%
2019-12-31	8.70%
2018-12-31	20.04%
2017-12-31	-10.38%
2016-12-31	8.14%
2015-12-31	0.86%
2014-12-31	-6.58%
2013-12-31	5.68%
2012-12-31	1.14%
2011-12-31	-2.36%
2010-12-31	-11.97%
2009-12-31	32.42%
2008-12-31	16.64%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Braveheart Bio, Inc. (BRVE)	United States	$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)	United States	$2.105B	-35.55
Trevi Therapeutics, Inc. (TRVI)	United States	$2.091B	-51.93
OCULAR THERAPEUTIX, INC (OCUL)	United States	$2.159B	-7.15
Prestige Consumer Healthcare Inc. (PBH)	United States	$2.163B	13.03
Generate Biomedicines, Inc. (GENB)	United States	$2.052B
PERRIGO Co plc (PRGO)	Ireland	$2.038B	-0.79
NEKTAR THERAPEUTICS (NKTR)	United States	$2.026B	-9.05
Aurinia Pharmaceuticals Inc. (AUPH)		$2.207B	7.18
UroGen Pharma Ltd. (URGN)		$2.015B	-18.42